Subsequently, a logistic regression model combining CK-18 M30, CAP, fasting plasma glucose, and HBV DNA level was established for diagnosis of NASH in CHB patients. The gene discussed is KRT18; the disease is metabolic dysfunction-associated steatohepatitis.